Asset Details
Do you wish to reserve the book?
Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition
Do you wish to request the book?
Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition
2019
Overview
Uterine carcinosarcoma is an aggressive variant of endometrial carcinoma characterized by unusual histologic features including discrete malignant epithelial and mesenchymal components (carcinoma and sarcoma). Recent studies have confirmed a monoclonal origin, and comprehensive genomic characterizations have identified mutations such as Tp53 and Pten. However, the biological origins and specific combination of driver events underpinning uterine carcinosarcoma have remained mysterious. Here, we explored the role of the tumor suppressor Fbxw7 in endometrial cancer through defined genetic model systems. Inactivation of Fbxw7 and Pten resulted in the formation of precancerous lesions (endometrioid intraepithelial neoplasia) and well-differentiated endometrioid adenocarcinomas. Surprisingly, all adenocarcinomas eventually developed into definitive uterine carcinosarcomas with carcinomatous and sarcomatous elements including heterologous differentiation, yielding a faithful genetically engineered model of this cancer type. Genomic analysis showed that most tumors spontaneously acquired Trp53 mutations, pointing to a triad of pathways (p53, PI3K, and Fbxw7) as the critical combination underpinning uterine carcinosarcoma, and to Fbxw7 as a key driver of this enigmatic endometrial cancer type. Lineage tracing provided formal genetic proof that the uterine carcinosarcoma cell of origin is an endometrial epithelial cell that subsequently undergoes a prominent epithelial–mesenchymal transition underlying the attainment of a highly invasive phenotype specifically driven by Fbxw7.
Publisher
National Academy of Sciences
Subject
1-Phosphatidylinositol 3-kinase
/ Animals
/ Cancer
/ Endometrial Neoplasms - genetics
/ Endometrial Neoplasms - metabolism
/ Endometrial Neoplasms - pathology
/ Epithelial-Mesenchymal Transition - physiology
/ F-Box-WD Repeat-Containing Protein 7 - genetics
/ F-Box-WD Repeat-Containing Protein 7 - metabolism
/ Female
/ Humans
/ Mice
/ Mutation
/ PTEN Phosphohydrolase - metabolism
/ Sarcoma
/ Tumor Suppressor Protein p53 - metabolism
/ Tumors
/ Uterine Neoplasms - genetics
/ Uterine Neoplasms - metabolism
/ Uterine Neoplasms - pathology
/ Uterus
